ScholarLens Back to search
2010•Internal Medicine of ChinaRequires access

Study of Ziprasidone in treatment of elderly schizophrenia

Feng Huang

Open publisher page 0 citations

Abstract

Objective To compare clinical efficacy and safety between ziprasidone and perphenazine in the treatment of elderly schizophrenia.Methods 72 cases of elderly patients with schizophrenia were randomly divided into ziprasidone group and perphenazine group for 8 weeks.Positive and Negative Syndrome Scale (PANSS) was used to assess the efficacy,side effects scale (TESS) was used to assess adverse reactions.Results After 8 weeks,effective rate of ziprasidone group was 69.44%,with a total effective rate was 88.89%;perphenazine group were 63.89% and 86.11%,respectively,no statistical difference in therapeutic effect (P0.05).However,compared to perphenazine group,adverse reactions of ziprasidone group were much smaller and lighter.Conclusion Ziprasidone in treatment of elderly schizophrenia is of good efficacy and relatively small adverse reactions.

About this research paper

What this paper is about

Objective To compare clinical efficacy and safety between ziprasidone and perphenazine in the treatment of elderly schizophrenia.Methods 72 cases of elderly patients with schizophrenia were randomly divided into ziprasidone group and perphenazine group for 8 weeks.Positive and Negative Syndrome Scale (PANSS) was used to assess the efficacy,side effects scale (TESS) was used to assess adverse reactions.Results After 8 weeks,effective rate of ziprasidone group was 69.44%,with a total effective rate was 88.89%;perphenazine group were 63.89% and 86.11%,respectively,no statistical difference in therapeutic effect (P0.05).However,compared to perphenazine group,adverse reactions of ziprasidone group were much smaller and lighter.Conclusion Ziprasidone in treatment of elderly schizophrenia is of good efficacy and relatively small adverse reactions.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To compare clinical efficacy and safety between ziprasidone and perphenazine in the treatment of elderly schizophrenia.Methods 72 cases of elderly patients with schizophrenia were randomly divided into ziprasidone group and perphenazine group for 8 weeks.Positive and Negative Syndrome Scale (PANSS) was used to assess the efficacy,side effects scale (TESS) was used to assess adverse reactions.Results After 8 weeks,effective rate of ziprasidone group was 69.44%,with a total effective rate was 88.89%;perphenazine group were 63.89% and 86.11%,respectively,no statistical difference in therapeutic effect (P0.05).However,compared to perphenazine group,adverse reactions of ziprasidone group were much smaller and lighter.Conclusion Ziprasidone in treatment of elderly schizophrenia is of good efficacy and relatively small adverse reactions.

Key concepts: Ziprasidone, Perphenazine, Medicine, Schizophrenia (object-oriented programming), Positive and Negative Syndrome Scale, Adverse effect, Internal medicine, Clinical efficacy

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Study of Ziprasidone in treatment of elderly schizophrenia — Research Paper | ScholarLens